| Literature DB >> 34368721 |
U U Nnadozie1,2, C D Umeokonkwo3, C C Maduba1, D Igwe-Okomiso3, C K Onah3, U C Madubueze3, C C Anikwe4, A Versporten5, I Pauwels5, H Goossens5, A U-O Ogbuanya2, O O Oduyebo6, E O Onwe7.
Abstract
BACKGROUND: Indiscriminate antimicrobial use is one of the greatest contributors to antimicrobial resistance. A low level of asepsis in hospitals and inadequate laboratory support have been adduced as reasons for indiscriminate use of antimicrobials among surgical patients. At present, there are no guidelines for presumptive antibiotic use in Nigeria and sub-Saharan Africa. AIM: Surgical inpatients at the study hospital were surveyed to determine the level of antimicrobial use and degree of compliance with prescription quality indicators.Entities:
Keywords: Antimicrobial guidelines; Antimicrobial resistance; Developing world; Presumptive antimicrobial therapy; Surgical inpatients
Year: 2020 PMID: 34368721 PMCID: PMC8336176 DOI: 10.1016/j.infpip.2020.100078
Source DB: PubMed Journal: Infect Prev Pract ISSN: 2590-0889
Prevalence of antimicrobial use by surgical ward
| Ward | Patients admitted ( | Prevalence of antimicrobial use (%) |
|---|---|---|
| Male surgical | 41 | 97.6 |
| Female surgical | 19 | 100.0 |
| Paediatric surgical | 15 | 93.3 |
| Plastic surgery | 7 | 100.0 |
| Total | 82 | 97.6 |
Antimicrobial quality indicators among surgical inpatients in a tertiary hospital
| Indicator | Antimicrobials ( | Percentage |
|---|---|---|
| Stop/review date | ||
| Yes | 219 | 98.2 |
| No | 4 | 1.8 |
| Treatment | ||
| Empirical | 211 | 94.6 |
| Targeted | 12 | 5.4 |
| Reason given in notes | ||
| Yes | 214 | 96.0 |
| No | 9 | 4.0 |
| Route of administration | ||
| Oral | 92 | 41.3 |
| Parenteral | 131 | 58.7 |
| Indication | ||
| Prophylactic | 127 | 57.0 |
| Therapeutic | 96 | 43.0 |
Demographic characteristics of the participants and reasons for antibiotic use (N=223)a
| Variable | Frequency | Proportion |
|---|---|---|
| Age (years) | ||
| 0–4 | 13 | 5.8 |
| 5–9 | 8 | 3.6 |
| 10–14 | 16 | 7.2 |
| 15–19 | 11 | 4.9 |
| 20–24 | 30 | 13.5 |
| 25–29 | 26 | 11.7 |
| 30–34 | 20 | 9.0 |
| 35–39 | 37 | 16.6 |
| 40–44 | 7 | 3.1 |
| 45–49 | 15 | 6.7 |
| ≥50 | 40 | 17.9 |
| Sex | ||
| Male | 171 | 76.7 |
| Female | 52 | 23.3 |
| Indication for antibiotic use | ||
| Community-acquired infection | 76 | 34.1 |
| Hospital-associated infection 1 | 12 | 5.4 |
| Hospital-associated infection 2 | 5 | 2.2 |
| Hospital-associated infection 4 | 3 | 1.4 |
| Surgical prophylaxis 1 | 13 | 5.8 |
| Surgical prophylaxis 2 | 1 | 0.45 |
| Surgical prophylaxis 3 | 113 | 50.7 |
Surgical prophylaxis: 1, given as single dose; 2, given within 24 h; 3, given for >24 h.
The table is based on the 223 antimicrobial encounters experienced by the respondents; a patient may have had more than one encounter.
Figure 1Duration of prescription for antimicrobial prophylaxis.